Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05).
| Image |  |
|---|---|
| Description | scientific article published on 23 September 2012 |
| Author/s |
author: Swiss Group for Clinical Cancer Research Oliver P Gautschi Elisabeth Oppliger Leibundgut Karin Ribi |
| Publication date | September 23, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |